Biotech: No Downside Risk Here – Barron’s


Barron's
Biotech: No Downside Risk Here
Barron's
Both the iShares Nasdaq Biotechnology ETF (IBB) and the SPDR S&P Biotech ETF (XBI) have risen 1.5% and 2.4% respectively, so far on Thursday. Oppenheimer's Leah Rush Cann notes that biotech stocks are trading at a 30% premium to the market.
Compton Capital Management Inc. RI Boosts Position in iShares NASDAQ Biotechnology Index (IBB)The Cerbat Gem
Neville Rodie & Shaw Inc. Boosts Position in iShares NASDAQ Biotechnology Index (IBB)Sports Perspectives
Alethea Capital Management LLC Maintains Stake in iShares NASDAQ Biotechnology Index (IBB)Chaffey Breeze
BBNS
all 23 news articles »

Read more here:
Biotech: No Downside Risk Here - Barron's

Related Posts

Comments are closed.